Skip to search formSkip to main contentSkip to account menu

in vitro-treated peripheral blood stem cell transplantation

Known as: in vitro-treated PBPC transplantation, peripheral blood stem cell transplantation, in vitro-treated, in vitro-treated peripheral blood progenitor cell transplantation 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Background Previous studies have shown that activated haplo-identical peripheral blood stem cell (haplo-PBSC) treatment exerts an… 
Review
2005
Review
2005
SummaryBacteriuria in pregnancy occurs in about one in 20 pregnant women and is usually initially asymptomatic. It is an… 
2000
2000
Engraftment was achieved in 43/45 (95%) recipients of peripheral blood stem cells (PBSC) from HLA-compatible unrelated donors (n… 
Highly Cited
1998
Highly Cited
1998
There is considerable interest in an autologous transplantation (AT) programme for patients with high‐risk breast cancer; however… 
Highly Cited
1997
Highly Cited
1997
The purpose of this study was to optimize the flow cytometric determination of circulating normal and malignant plasma cells (PC… 
1997
1997
The outcomes for patients with non-Hodgkin’s lymphoma (NHL) treated with high-dose chemotherapy (HDC) and peripheral blood stem… 
Review
1997
Review
1997
Here we review our recent experience addressing the issue of positive selection and transplantation of hematopoietic CD34+ cells… 
1997
1997
Incubating hematopoietic stem cells with IL-2 in vitro for 24 h generates cytotoxic T cells. When infused into patients, these… 
Review
1996
Review
1996
Previous studies of PBPC BMR have found evidence supporting its safety, feasibility, and efficacy when used in a wide range of…